Literature DB >> 1900309

A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.

L B Giebel1, R K Tripathi, R A King, R A Spritz.   

Abstract

Type I oculocutaneous albinism (OCA) is an autosomal recessive disorder in which deficient synthesis of melanin pigment results from abnormal activity of melanocyte tyrosinase. A novel type I OCA phenotype in which hypopigmentation is related to local body temperature is associated with a missense substitution in tyrosinase, codon 422 CGG (Arg)----CAG (Gln). This substitution results in a tyrosinase polypeptide that is temperature-sensitive. This form of type I OCA thus is homologous to the temperature-related forms of albinism seen in the Siamese cat and the Himalayan mouse.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900309      PMCID: PMC329910          DOI: 10.1172/JCI115075

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism.

Authors:  R A Spritz; K M Strunk; C L Hsieh; G S Sekhon; U Francke
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

2.  Molecular basis of mouse Himalayan mutation.

Authors:  B S Kwon; R Halaban; C Chintamaneni
Journal:  Biochem Biophys Res Commun       Date:  1989-05-30       Impact factor: 3.575

3.  Characteristic sequences in the upstream region of the human tyrosinase gene.

Authors:  H Kikuchi; H Miura; H Yamamoto; T Takeuchi; T Dei; M Watanabe
Journal:  Biochim Biophys Acta       Date:  1989-12-22

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

Review 5.  Albinism.

Authors:  R A King; C G Summers
Journal:  Dermatol Clin       Date:  1988-04       Impact factor: 3.478

6.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

7.  Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene.

Authors:  Y Tomita; A Takeda; S Okinaga; H Tagami; S Shibahara
Journal:  Biochem Biophys Res Commun       Date:  1989-11-15       Impact factor: 3.575

8.  pH-dependent interconversion of two forms of tyrosinase in human skin.

Authors:  R K Tripathi; C Chaya Devi; A Ramaiah
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

9.  Tyrosinases of murine melanocytes with mutations at the albino locus.

Authors:  R Halaban; G Moellmann; A Tamura; B S Kwon; E Kuklinska; S H Pomerantz; A B Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA.

Authors:  B Bouchard; B B Fuller; S Vijayasaradhi; A N Houghton
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  28 in total

1.  The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12.

Authors:  M Ramsay; M A Colman; G Stevens; E Zwane; J Kromberg; M Farrall; T Jenkins
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

2.  The Tyr (albino) locus of the laboratory mouse.

Authors:  Friedrich Beermann; Seth J Orlow; M Lynn Lamoreux
Journal:  Mamm Genome       Date:  2004-10       Impact factor: 2.957

3.  Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".

Authors:  R E Boissy; H Zhao; W S Oetting; L M Austin; S C Wildenberg; Y L Boissy; Y Zhao; R A Sturm; V J Hearing; R A King; J J Nordlund
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

4.  Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism.

Authors:  W S Oetting; M M Mentink; C G Summers; R A Lewis; J G White; R A King
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

5.  Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.

Authors:  R Halaban; S Svedine; E Cheng; Y Smicun; R Aron; D N Hebert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 6.  Albinism: modern molecular diagnosis.

Authors:  S M Carden; R E Boissy; P J Schoettker; W V Good
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

7.  Update on the regulation of mammalian melanocyte function and skin pigmentation.

Authors:  Taisuke Kondo; Vincent J Hearing
Journal:  Expert Rev Dermatol       Date:  2011-02-01

8.  Study of the docking of competitive inhibitors at a model of tyrosinase active site: insights from joint broken-symmetry/Spin-Flip DFT computations and ELF topological analysis.

Authors:  A de la Lande; J Maddaluno; O Parisel; T A Darden; J-P Piquemal
Journal:  Interdiscip Sci       Date:  2010-03       Impact factor: 2.233

9.  Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism.

Authors:  L B Giebel; R K Tripathi; K M Strunk; J M Hanifin; C E Jackson; R A King; R A Spritz
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

10.  Initial sequence and comparative analysis of the cat genome.

Authors:  Joan U Pontius; James C Mullikin; Douglas R Smith; Kerstin Lindblad-Toh; Sante Gnerre; Michele Clamp; Jean Chang; Robert Stephens; Beena Neelam; Natalia Volfovsky; Alejandro A Schäffer; Richa Agarwala; Kristina Narfström; William J Murphy; Urs Giger; Alfred L Roca; Agostinho Antunes; Marilyn Menotti-Raymond; Naoya Yuhki; Jill Pecon-Slattery; Warren E Johnson; Guillaume Bourque; Glenn Tesler; Stephen J O'Brien
Journal:  Genome Res       Date:  2007-11       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.